Profhilo®, skin boosters and hyaluronic acid fillers are often mentioned side by side in aesthetic medicine. This can create the impression that they are merely different brand names for the same treatment. In reality, their objectives, material properties and target tissue layers differ. Profhilo® is mainly associated with skin quality, hydration and elasticity. A volumising filler, by contrast, is often intended to alter a specific contour or projection. Understanding the difference helps people set more realistic expectations and ask more focused questions during a medical consultation.
The term bio-remodelling describes a treatment concept, not a guarantee of success. Injectable hyaluronic acid can bind water, influence tissue mechanically and trigger biological responses. How clearly these effects become visible in practice depends on the specific product, treatment area, starting condition and method of measurement. Even an outcome perceived as fresher or more rested does not automatically prove that a particular amount of new collagen or adipose tissue has formed.
What exactly is Profhilo®?
Profhilo® is an injectable product made from high- and low-molecular-weight hyaluronic acid. A published material study describes the standard formulation as containing 32 milligrams of hyaluronic acid per millilitre, supplied in a two-millilitre syringe. The hyaluronic acid forms what is called a Hybrid Cooperative Complex. Its manufacturing process is known as NAHYCO® technology and does not use the chemical cross-linking found in many conventional fillers. This composition explains the material's comparatively fluid properties, but it does not by itself predict an individual's outcome.
Laboratory studies describe effects in cell models and on markers related to collagen and elastin. Such findings help explain a possible mechanism, but they cannot be translated directly into a visible treatment result. Clinical studies matter more to patients: were hydration, elasticity, density or wrinkles actually measured in people? How large was the group, was there a comparator and who supported the research? Only these questions turn a plausible mechanism into useful evidence for a decision.
How do Profhilo®, skin boosters and fillers differ?
- Profhilo®: a specific hyaluronic acid formulation mainly studied in relation to skin quality, hydration, elasticity and skin laxity.
- Skin booster: an umbrella term for different injectable products. Concentration, cross-linking, added ingredients, flow properties and treatment objectives may vary considerably.
- Volumising filler: usually more structure-giving hyaluronic acid products intended to alter volume, projection or contour in a targeted way.
- Collagen stimulators: materials for which a gradual tissue response is central. They may also influence volume, but they are not equivalent to Profhilo®.
These categories partly overlap. Hyaluronic acid can bind water, occupy space and influence cellular responses at the same time. The question 'Which is stronger?' is therefore usually less useful than 'What is meant to change?'. Skin that appears dry or less elastic presents a different starting point from a clear volume deficit in the cheek or chin. A product name cannot replace examination or a clear explanation of why that particular material may fit the desired change.
What does the evidence show for Profhilo®?
A systematic review of injectable hyaluronic acid screened 2,996 publications and included 13 clinical studies. The combined findings were promising for several features of facial skin, including hydration, firmness, texture and elasticity. However, the products and protocols differed. The authors explicitly call for larger randomised controlled trials. This qualification is important: an encouraging overall signal is not the same as a certain benefit for every product, treatment area and individual.
An additional meta-analysis published in 2025 brought together twelve studies of different hyaluronic acid injections; only six provided comparable data for statistical pooling. Measured skin hydration and radiance improved compared with control groups. Elasticity and the melanin index, however, showed no statistically significant difference. Products, measurement methods and treatment protocols varied. This evidence for a class of injections must therefore not be presented as a Profhilo®-specific success rate. It is more useful for asking a precise question: which measured outcome matches the individual goal, and has the particular product been studied for it?
A more recent systematic review specifically addressing Profhilo® and Profhilo® Body summarised nine studies involving 278 participants. It reported changes or trends in hydration, elasticity, density, skin laxity and wrinkle measures. The studies were small and heterogeneous, and several authors of the review work for the manufacturer. This does not make the findings meaningless, but it requires transparency and restraint. The data can inform medical assessment; they do not support a promise of a particular result or fixed duration.
What does a typical Profhilo® treatment involve?
Before any injection, the consultation should cover the desired objective, previous aesthetic procedures, medication, allergies, acute skin problems and relevant medical conditions. The treatment area, product and injection plane are then determined. Publications on Profhilo® describe standardised point-based techniques, including Bio Aesthetic Points. Such protocols support reproducible use, but they are not a universal recipe for every face or body area. Anatomy, skin findings, the approved product information and medical judgement remain decisive.
Many clinical studies of Profhilo® used two treatments about one month apart. An observational study of Profhilo® Structura also used two monthly treatments. These details describe research protocols, not a mandatory schedule at PRECIOUS. Whether one procedure, a series or a later maintenance treatment is appropriate must be reassessed after examination, tolerability and outcome. The onset of change, downtime and duration likewise cannot be predicted reliably for one individual from a general study protocol alone.
How is Profhilo® Structura different?
Profhilo® Structura is not simply a stronger version of the same skin treatment. A published material analysis describes 45 milligrams of hyaluronic acid per millilitre, compared with 32 milligrams per millilitre for standard Profhilo®. More importantly, the target tissue and clinical question differ: Structura has been studied for facial fat compartments, whereas standard Profhilo® is more closely associated with skin quality and laxity. A person concerned about flatter cheeks or a changing jawline is therefore asking a different question from someone concerned about skin that appears dry or thin.
In an open-label pilot study, 50 women with volume loss in the lateral cheek received two Structura treatments one month apart. Clinician-rated scales improved from baseline, with final follow-up three months after the second treatment. Without an untreated comparison group, however, it is impossible to separate confidently how much of the observed effect arose from the material, injection volume, participant selection or assessment. Statements such as 'fat tissue is regenerated' should therefore not be understood as a proven individual effect. The separate Structura guide explores these evidential limitations in greater depth.
Which side effects and risks belong in the consent discussion?
Pain, redness, swelling, tenderness, bruising or temporary irregularities may occur after hyaluronic acid injections. In the systematic Profhilo® review, reported events were generally mild and transient. Small studies and manufacturer data, however, have limited ability to detect rare complications. 'Well tolerated' should therefore never be read as 'risk free'. Delayed inflammatory reactions, infection, nodules or discolouration also need to be explained clearly before a decision.
Rare vascular complications, including serious outcomes, have been described with hyaluronic acid fillers. The available consensus data mainly concern fillers and must not be interpreted as a product-specific rate for Profhilo®. They nevertheless show why facial injections require anatomical expertise and concrete preparedness for emergencies. Unusually severe pain, marked skin discolouration, visual symptoms or rapidly worsening problems after an injection require immediate medical assessment. These are warning signs, not an expected normal course.
What matters after treatment?
Aftercare advice needs to match the treated area, the product used and the actual technique. General lists found online cannot replace individual instructions. It is important to keep injection sites clean, avoid unnecessary irritation and follow medical advice on exercise, heat, sun exposure, skincare and medication. Before treatment, patients should also know whom to contact with questions or unusual symptoms. Good aftercare is not merely a list of restrictions; it provides clear thresholds for when medical contact is needed.
Which questions support the decision?
- Is the main concern skin quality and hydration, or a clear loss of volume and contour?
- Which specific product will be used, and which published evidence relates to that objective?
- Which common and rare risks apply to the treatment area, material and technique?
- How will it be decided whether another session is appropriate or a different approach would fit better?
- What will the planned medical service cost, and what is included?
The PRECIOUS service page lists Profhilo®, Nucleofill and Sunekos within biostimulators and skin boosters. The private practice in Wiesbaden combines aesthetic medicine, internal medicine and longevity, with services billed privately under the German medical fee schedule, GOÄ. The hyaluronic acid page lists skin booster treatment from EUR 200. This is not an automatic price for Profhilo®; the cost of the planned medical service should be discussed transparently before treatment. The appropriate area, formulation and number of sessions remain an individual medical decision. Appointments can be arranged by telephone, WhatsApp, email or through online booking around the clock.
Sources
- Ghatge and Ghatge: systematic review of injectable hyaluronic acid and facial skin, PubMed PMID 37038447.
- Zhou and Yu: Systematic review and meta-analysis of hyaluronic acid injections and skin quality, PubMed PMID 39807700.
- Sparavigna et al.: systematic review of Profhilo® and Profhilo® Body, PubMed PMID 41920062; manufacturer interests need to be considered when interpreting the findings.
- Scrima et al.: material study of hyaluronic acid formulations including Profhilo® and Profhilo® Structura, PubMed PMID 36523543.
- Sparavigna et al.: open-label pilot study of Profhilo® Structura for lateral cheek volume loss, PubMed PMID 38260185.
- Signorini et al.: international consensus on complications from hyaluronic acid fillers, PubMed PMID 27219265.
